...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155


BREAKING: Spyder Cannabis Celebrates Canada Day Weekend with Launch of New Hemp Energy Drink Line

  • In celebration of Canada Day, it will launch its new Hemp Energy Drink line over the Canada Day long weekend across its existing Ontario locations, as well as its two brand new stores in Niagara Falls and Pickering, set to open this weekend
  • Samples will be available at all locations

Spdr logo large

Hub On AGORACOM / Read Release

Message: AGM 2018 - Masila Notes

This is I think where I got the idea that patients might have the option to continue taking Apabetalone after the trial wrapped up....from masila's notes from Sept's AGM, the post to which I am replying....here's the relevant section that probably led me to think this:  

Apparently all patients interviewed want to stay on the treatment.  Some have been on close to 36 months.  That speaks volumes to me! 

New Message
Please login to post a reply